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ABSTRACT

The cover of the heart, or epicardium, consists of a single layer of mesothelial
cells. During cardiac development, epicardial cells undergo Epithelial-to-Mesenchymal
Transition (EMT) to form multipotent precursors known as epicardial-derived cells
(EPDC). The EPDC migrate into myocardial tissue (containing cardiomyocytes) and
subsequently differentiate into fibroblasts, myofibroblasts, and smooth muscle cells. In
adult hearts, a similar process of epicardial cell proliferation, migration, and
differentiation occurs after myocardial infarction (MI, heart attack). EPDC differentiation
into vascular endothelial cells or cardiomyocytes is rare and not well understood.
Recently, we observed that running (exercise) in mice promotes differentiation of EPDC
into microvascular endothelial cells (CD31+). After running, EPDC appear to generate
endothelial cells and not other cardiac cell types. Of interest, running promotes cardiac
hypertrophy that requires additional perfusion (blood flow) and may therefore stimulate
the contribution of EPDC to capillaries. We hypothesized that running exercise induces
gene expression in epicardial cells that promotes endothelial specification. To test our
hypothesis, we developed an efficient method to directly isolate primary adult epicardial
cells from the heart cover based on their expression of integrin-β4 (CD104). After 2
hours of protease digestion, we used Magnetic-Activated Cell Sorting with antibodies
against CD104 (CD104 MACS) to obtain undifferentiated epicardial cells; this was
confirmed by expression of Keratin-18, an epicardial-specific protein in the heart. By
cDNA microarray assays and bioinformatics analysis, we compared the gene expression
profile of epicardial cells isolated from running-conditioned mice with that of agematched controls (non-runners). Our data suggest that extracellular matrix remodeling in
the heart is mediated, in part, by epicardial cells during running. Furthermore, we identify
epicardial gene expression for cell signals/pathways and transcription factors that may
enhance vascular perfusion after MI through promoting angiogenesis or endothelial
specification of epicardial derivatives.
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CHAPTER 1: INTRODUCTION
1.1. Project relevance to cardiovascular disease
Myocardial Infarction (MI, heart attack) is a sudden and sometimes fatal
occlusion of blood flow and nutrient exchange within the myocardium. The inadequate
nutrient exchange and oxygen supply between the cardiac vasculature and
cardiomyocytes (i.e., cardiac muscle cells) results in local cell death and tissue necrosis
(White et al. 2014). The size of the resulting infarct and patient prognosis depend on
several parameters such as time to revascularization and degree of reperfusion achieved
upon recanalization of the occluded blood vessel.
A leading cause of death, MI affects one in four individuals worldwide
(Mozaffarian et al. 2016). In 2015, approximately 735,000 people suffered a heart attack
in the United States (Mozaffarian et al. 2016). Current hospital interventions to treat MI
promote reperfusion to the area of infarct by chemical removal of the clot (a.k.a.
thrombolysis), or through mechanical means such as stenting (NIH: National Heart,
Lung, and Blood Institute available online, updated Nov. 2016; Pasotti, Prati, &
Arbustini, 2006). Depending on the extent of damage to the heart, cardiac function may
continue to decline, even when the thrombus has been successfully removed.
MI results in widespread changes in cellular communication. In tissue with
infarction, soluble signaling molecules such as growth factors, cytokines, chemokines,
and other chemical mediators (e.g., adenosine triphosphate [ATP], reactive oxygen
species, nitric oxide) are released from cardiac myocytes, vascular cells, fibroblasts, and
immune cells that elicit responses from various other cell types, including epicardial cells
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(Murphy & Steenbergen 2008; Cochain et al. 2013; Horckmans et al. 2016). In the days
that follow MI, interstitial fibroblasts, including those that derive from epicardial cells
(for details, see below), secrete extracellular matrix to form scar tissue in the necrotic
zone (Shinde & Frangogiannis 2014). Although it may eventually lead to cardiac
stiffening with potential to promote cardiac failure, in the short-term, cardiac scar
formation prevents ventricular rupture and death.

1.2 Background to epicardial and cardiac cell biology
The heart is comprised of cardiomyocytes, interstitial fibroblasts, neurons
(Purkinje cells), and a complex, interweaving vasculature comprised of endothelial cells,
smooth muscle cells, adventitial fibroblasts, and pericytes (Xin et al. 2013). The heart also
contains endocardial cells that form its inner lining, and epicardial cells, that cover its
surface. The unique phenotype and function(s) of each cardiac cell type results, in part,
from cell signaling, gene transcription and protein expression established during
development. For example, growth factors (e.g., BMPs, Wnt/β-catenin, FGFs,
Activin/Nodal) direct cardiac myocyte specification during development by activating
specific networks of genes that encode transcription factors such as Nkx 2.5, Isl-1, Tbx5,
and the receptor, Flk-1 (Später et al. 2014; Olson 2006). To maintain cellular phenotype in
adults, genes/proteins for some transcription factors and receptors continue to be expressed
(e.g., Gata4) (Evans et al. 2010). Cell-cell communication plays an essential role in
relaying information about the physiologic or pathophysiologic state of the heart and other
organs. These signals, in turn, influence cardiac function. Other cell types that affect
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cardiac function through signaling include immune cells and innervating neural cells (Xin
et al. 2013).
During development, the cells that comprise the pro-epicardial organ form the
“epicardium”, or outer-most layer of the heart (Pérez-Pomares & Muñoz-Chápuli 2002;
Reese et al. 2002). Epicardial cells undergo epithelial-to-mesenchymal transformation
(EMT), migrating into the heart to produce epicardial derivatives: vascular smooth muscle
cells, myofibroblasts, and perivascular fibroblasts that contribute to the formation of the
capillary plexus, a vascular network that includes the coronary arteries (Dettman et al.
1998; Reese et al. 2002). During this process, simultaneous changes in EMT-associated
transcription factors, migration machinery, cytoskeletal architecture and ECM composition
allow epithelial-like epicardial cells to adopt a more mesenchymal, migratory phenotype
(Cano et al. 2000; Männer et al. 2001; Thiery et al. 2009)
The adult epicardium is formed by mesothelial cells that do not usually undergo
EMT and that remain on the heart surface. This single cell layer is adherent to the
subepicardial extracellular matrix and surrounded by pericardial fluid, a lubricant that
reduces friction for the heart as it beats within the pericardial sac. The expression of
transcription factors (e.g. Tbx18, Wt-1) and cytoskeletal proteins (e.g. Keratin-18) is used
to identify epicardial cells (Thorey et al. 1993; Zeng et al. 2011). Adult epicardial cells are
typically quiescent but retain their competence for EMT and migration (Figure 1). As such,
they have recently have been identified as an important source of cells for cardiac
regeneration after injury (Masters & Riley 2014). During MI, the fetal epicardial program
is “re-activated,” inducing epicardial cells to lose apical-basal polarity and undergo EMT
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to form multipotent progenitor cells, called epicardial-derived cells (EPDC) (Zhou et al.
2011; von Gise & Pu 2012). After MI, EPDC migrate through the subepicardium toward
areas of infarction (Smart et al. 2013), contributing to the population of cardiac fibroblasts,
smooth muscle cells, and to a much lesser extent cardiomyocytes and endothelial cells
(Reviewed in Wessels & Pérez-Pomares 2004)

4

Figure 1. Diagram of epicardial cell layer involved in differentiation. After EMT, precursor cells migrate
through the subepicardium and into the myocardium where they may differentiate in various cardiac cell
types. EMT= Epithelial-to-Mesenchymal Transition.
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In recent work, the Spees Lab developed tools and methods to prime cardiac
stem/progenitor cells (CPCs), including EPDC, for delivery to subepicardial sites in order
to promote graft success after MI. Importantly, we found that priming cells in a defined
combination of C-terminal (4th domain) peptide of Connective Tissue Growth Factor
(CTGF-D4) and Insulin supported the survival of grafted cells and also their migration
into cardiac tissue with necrosis (Iso et al. 2014) (Rao et al., under review). We
hypothesize that this system can be utilized to promote neovascularization and improve
cardiac regeneration and function after MI.

1.3 Neovascularization is observed after running exercise, but not myocardial
infarction
To better understand the role of the adult epicardium in angiogenesis and vascular
preservation/repair after cardiac injury, we are also studying the cell biology of healthy
hearts using a mouse model of running-exercise, focusing on the changes that occur in
epicardial cells. In adults, running-exercise promotes compensatory changes that improve
cardiac performance (function); these changes can contribute to a healthy cardiovascular
system and reduce the incidence of cardiovascular disease. Similar to the case for humans
and other mammals, running-exercise in mice increases VEGF production and promotes
neovascularization that enhances vascular perfusion to support cardiac hypertrophy (i.e.,
muscle growth) (Asahara et al. 1999; Kehat & Molkentin 2010). In preliminary studies,
we found that running-exercise induced epicardial EMT and the differentiation of EPDC
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derivatives into microvascular CD31+ endothelial cells that contributed to capillary
formation (K. S. Rao, PhD dissertation; University of Vermont).

Importantly, identification of the signaling mechanisms responsible for the
positive changes that occur during running-exercise may help to develop therapeutic
approaches to improve cardiac perfusion after ischemic injury. Within this Master’s
Thesis, I provide the first report of epicardial gene expression that occurs in response to
running-exercise. Furthermore, I discuss the transcriptional profiling results in terms of
cardiac development, remodeling, and cell signaling. Notably, our data may provide a
road map for pro-angiogenic signals and pathways that can potentially be exploited to
induce endothelial cell fate from adult epicardial cells and/or EPDC in the context of MI.
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Chapter 2: METHODS
2.1 Background

To study changes in epicardial cells during running exercise, we developed a
novel method for epicardial cell isolation. Other groups have studied epicardial cells by
“explant culture”, wherein small pieces of cardiac tissue are physically dissected from the
heart cover and allowed to adhere in cell culture for 3 days to 1 week (Kim et al. 2012;
Greulich et al. 2012). While the explant approach can yield 105-106 epicardial cells from
a single heart grown in a cell culture dish, it has major disadvantages that may contribute
to data artifact(s) and misinterpretation of regulatory mechanisms that operate in vivo. In
addition to the potential for heterogeneity within the population of isolated cells, the
extended time that cells spend in culture is also a problem (i.e., adhered to plastic culture
dishes and bathed in serum-containing medium). Culture of primary epicardial cells is
well known to induce proliferation and EMT (Described in Lamouille et al. 2014).
The main objective of our study was to identify key differences in epicardial cell
gene transcription between mice that engaged in running-exercise over a 1-week period
compared with aged-matched (non-running) controls. To minimize transcriptional
changes in epicardial cells during the isolation process, we used both chemical and
mechanical means to carefully remove epicardial cells from the heart in a rapid and
efficient manner. To minimize destruction of cell surface epitopes (e.g., receptors,
integrins, etc.) and avoid activation of intracellular signaling cascades, we incubated
individual hearts in an enzyme solution that contained concentrated collagenase and
dispase, but not other proteases. Moreover, we incubated hearts with low-dose
8

cyclosporine A to promote cell survival (Jung et al. 2008; Sachewsky et al. 2014). To
further optimize this approach, we simultaneously performed mechanical/chemical digest
by employing constant, gentle shaking with specialized equipment. Importantly, these
methods isolate primary adult epicardial cells from adult mice while reducing
contamination by other cell types, including fibroblasts and blood cells.
Previously, we identified an epicardial-specific cell marker for the heart, CD104
(integrin-β4). Expression of CD104 is exclusive to epicardial cells of the heart, as
demonstrated by immunohistochemistry of cardiac tissue sections and by
immunofluorescence staining of isolated cells after enrichment by Fluorescent-Activated
cell Sorting (FACS) (Rao, et al., under review). Accordingly, we took advantage of the
specificity of CD104, and performed Magnetic-Activated Cell Sorting (CD104 MACS)
to further enrich epicardial cells. Subsequently, we confirmed this result by staining cells
isolated by CD104 MACS with antisera against Keratin-18, a specific marker of
epicardial cells in the heart (Rao et. al., PhD dissertation; University of Vermont). To our
surprise, we found that the majority of cells isolated by our initial chemical/mechanical
digest method were Keratin-18+, even before sorting. By CD104 MACS, we were able to
increase the number of Keratin-18+ cells obtained, indicating further enrichment for
native epicardial cells in the population. Applying our isolation method, and CD104
MACS, we then isolated total RNA from primary epicardial cells of runners and nonrunners and generated transcriptional profiles using cDNA microarrays (Figure 2).
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Figure 2. Schematic overview of heart digest and epicardial cell isolation method. N = 5 mice (C57BL/6J,
males, 10-weeks of age) per group, housed either with or without a running wheel and odometer. Cell
culture incubator was maintained at 37°C, 5% O2 See Methods for details.

10

2.2 Running exercise in adult mice
C57BL/6J mice (males, 10 weeks of age; from The Jackson Laboratory, Bar
Harbor, ME) were allowed to run ad libitum for 1 week before euthanization and heart
harvest. Experimental mice (n = 10 total) were housed individually, provided food and
water ad libitum. Each mouse cage was equipped with a running wheel and an attached
odometer (CatEye America, Boulder, CO), generously provided by Dr. William Falls,
Department of Psychology, University of Vermont. Running distances were recorded
every 1 to 2 days. Age-matched male control mice (n = 10) were housed and fed
similarly, except without running wheels. All animal work was conducted in accordance
with a protocol approved by the Institutional Animal Care and Use Committee of the
University of Vermont (IACUC protocol 08-016).

2.3 Epicardial cell isolation
2.3.1 Heart dissection
A sterile fume hood was cleansed with 70% ethanol (Sigma-Aldrich) and exposed
to UV light for 15 minutes prior to heart dissection. Each mouse was anesthetized by
isoflurane inhalation for 2 minutes (4%, to effect) and underwent cervical dislocation
before dissection. After placing the mouse in the fume hood, on a pre-sterilized stainless
steel container (ventral side facing up), the fur was cleansed with a 70% ethanol wipe and
a central incision was made just below the sternum. The skin was cut laterally below the
ribs and the sternum was retracted with a hemostat (Fine Science Tools, Foster City, CA)
to expose the diaphragm. A medial incision was made in the diaphragm and cut laterally
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toward each side to expose the heart. To clear blood cells by trans-cardiac perfusion,
approximately twenty (20) ml of 1x Phosphate Buffered Saline (PBS; Corning, Corning,
NY) was injected into the left ventricle (clearance of blood indicated by a blanching
change in color in the lungs and liver). The aorta and large vessels were cut and the heart
was removed and immediately rinsed with 1x PBS at room temperature (to remove
excess blood). The heart was transferred to a solution containing 1x Hank’s Balanced Salt
Solution (HBSS; Sigma-Aldrich, St. Louis, MO) and maintained at room temperature for
no more than 15 minutes. Individual hearts were then transferred into the wells of tissue
culture plates that contained the solution for enzymatic digestion.

2.3.2 Enzymatic digestion of the heart cover with collagenase/dispase
Digest solution was freshly prepared on the day of isolation and kept on ice. It
consisted of HBSS supplemented with 5 μg/ml Collagenase/Dispase (Roche Diagnostics
GmbH, Mannheim, Germany) and 10 μM Cyclosporine A (Cayman Chemical Company,
Ann Arbor, Michigan). Hearts were placed into individual wells of a 24-well plate
(Fisher, Pittsburg, PA) and fully submerged into 1 ml of digest solution. The plate was
taped to a plastic weigh boat containing a magnetic stir bar, placed on a battery-operated
magnetic stirrer (Elmco Engineering, Rockville, MD) and then transferred to an incubator
that was maintained at 37°C and 5% CO2 for 2 hours.
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2.3.3 CD104 Magnetic-Activated Cell Sorting (CD104 MACS).
Isolated cells from individual hearts were pooled according to experimental group
(running versus non-running). Cells were collected into 50 ml conical tubes (Falcon).
Hearts were washed twice in 1x PBS and cells were collected. Cells were centrifuged at
800 x g for 8 minutes at 22°C, carefully triturated with a glass Pasteur pipette, and gently
re-suspended in 500 μL of MACS buffer. MACS buffer was prepared as α-Minimum
Essential Medium (MEM, Sigma) supplemented with 2 mM EDTA (Sigma-Aldrich) and
0.5% Biotin-free BSA (Sigma). Immediately after re-suspension in 500 μl MACS buffer,
cells were incubated with rat anti-mouse CD104 antibody (1:100, MCA2369;
AbDSerotec, Raleigh, NC) for 30 minutes on ice, with gentle agitation every five
minutes. After incubation, cells were gently washed with 30 ml MACS buffer and mixed
by inversion. Cells were centrifuged at 800 x g for 8 minutes, re-suspended in 800 μl of
MACS buffer, and 200 μl of anti-rat IgG microbeads (Miltenyi, San Diego, CA) was
added to the solution. Cells were incubated on ice for another 30 minutes, with gentle
agitation every 5 minutes, and then washed with 30 ml of MACS buffer before
centrifugation at 800 x g for 8 minutes. LS-Columns (Miltenyi Biotech, Bergisch
Gladbach, Germany) were placed onto a QuadroMACS Separator (Miltenyi Biotech) at
4°C for 10 minutes prior to use. Columns were equilibrated with 5 ml MACS buffer and
cells were re-suspended in 5 mL MACS buffer and placed onto the column. Cells labeled
with MACS Microbeads were held in suspension within the column by the MACS
Separator magnetic field and released after three washes with MACS buffer. Cells were
eluted from the column in 5 ml MACS buffer. The CD104-positive fraction was collected
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in a sterile, separate tube. Cells were centrifuged at 800 x g for 8 minutes, resuspended in
MACS buffer, and a cell count was performed by hemocytometer.

2.4 RNA isolation
Total RNA was isolated with the Quick-RNA MicroPrep kit as per the
manufacturer’s instructions (Zymo Research Corp., Irvine, CA). Briefly, cells were resuspended in 100 μl RNA Lysis Buffer and vortexed for 2 seconds. To the solution, 100
μl of 100% Ethanol was added to the samples and mixed by vortexing. The sample was
transferred to a Zymo-Spin IC Column with Collection Tube and centrifuged. All
centrifugations took place at 15,000 x g for 30 seconds at room temperature and flowthrough was removed after each centrifugation. The samples were immobilized on the
column and treated with DNase I for 15 minutes at room temperature and then the
column was centrifuged. RNA Prep Buffer was added to the column and then centrifuged
for 30 seconds. The sample was washed twice with RNA Wash Buffer and then eluted
from the column with DNase/RNase-free water into an RNase-free tube. Sample
concentrations were measured with a spectrophotometer at λ= 260/280 nm and 260/230
nm and stored at -80°C before submission to the DNA Core Facility (University of
Vermont, Burlington).

2.5 Cell culture, antibodies, and immunocytochemistry
After isolation, cells were plated in α-MEM (Sigma) containing 10% fetal bovine
serum (FBS; Gibco/Life Technologies, Grand Island, NY), 10 μM L-glutamine, and 10
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μM penicillin/streptomycin (Gibco/Life Technologies, Carlsbad, CA) and then plated on
sterile glass coverslips in a 24-well plate (Fisher). Cells were transferred to an incubator
that was maintained at 37°C with 5% CO2 and allowed to adhere for 24 hours before
fixation. After a gentle wash with 1x PBS, cells were fixed with cold 4%
paraformaldehyde (Miltenyi) for 15 minutes at room temperature. Fresh blocking buffer
was prepared in 1x PBS with 0.25% Triton-X 100 and 3% goat serum. Cells were
incubated with blocking buffer for 1 hour at room temperature. Rabbit anti-Keratin-18
antibody was prepared in blocking buffer (1:500, Sigma-Aldrich, C-terminal antibody).
Cells were incubated with primary antibody overnight at 4°C and then washed thrice with
1 x PBS at room temperature. Goat anti-Rabbit AlexaFluor 594 was prepared in blocking
buffer (1:500 vol/vol) and cells were incubated with secondary antibody for 1 hour at
room temperature. After 3 washes with 1 x PBS at room temperature, coverslips were
mounted with Vectashield containing DAPI (Vector Laboratories, Burlingame, CA) and
stored at 4°C until visualization by epi-fluorescence microscopy. Images were captured
using a Leica DM600B microscope equipped with a CCD camera (Leica DFC350Fx) and
FW4000 software using channels to visualize nuclei at λ= 355 nm and intermediate
filaments at λ= 594 nm for 15 ms and 200 ms, respectively. Images were captured at 20x
and 40x with PlanApo objectives (Leica).

2.6 Microarray analysis
2.6.1. Running-exercised and control sample microarray
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RNA samples were submitted to the UVM Advanced Genome Technologies Core
(UVM AGTC). Oligonucleotide microarray analysis of RNA expression levels was
performed using the Affymetrix GeneChip, Mouse Gene 2.0 ST (Affymetrix Inc., Santa
Clara, CA) according to manufacturer’s protocols. In brief, an RNA input of 50 ng was
used to generate cDNA through First Strand and Second Strand synthesis reactions
(Ovation® Pico WTA System V2, NuGEN). The cDNA samples were then purified
using an Agencourt® RNAClean® XP magnetic bead protocol. Following purification,
samples were amplified using SPIA reagents (Ovation® Pico WTA System V2,
NuGEN). A final cDNA purification was performed (Agencourt® RNAClean® XP).
Sample concentrations were determined with 33 μg/mL/A260 constant on a Nanodrop
1000 Spectrophotometer. Approximately 4 μg of cDNA was fragmented and labeled
(Encore® Biotin Module, NuGEN). Efficiency of the biotin labeling reaction was
verified using NeutrAvidin (10 mg/mL) and a gel-shift assay. Samples were injected into
arrays and placed into an Affymetrix Genechip® Hybridization Oven 640 at 45° C and
60 RPM for 16-18 hours. Arrays were stained using the Affymetrix Genechip® Fluidics
Station 450 and scanned with the 7G Affymetrix Genechip® Scanner 3000.

2.6.2. Array data analysis

Probe set statistics and identification of differential expression was performed
by the Molecular Bioinformatics Shared Resource of the University of Vermont College
of Medicine using Partek Genomics Suite® Version 6.6 (Partek Inc., St. Louis, MO).
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Probe-level intensities were calculated using the Robust Multichip Average (RMA)
algorithm, including background-correction, normalization (quantile), and summarization
(median polish), for each probe set and sample. Sample quality was assessed based on 3’:
5’ ratio, relative log expression (RLE), and normalized unscaled standard error (NUSE).
Principal Component Analysis (PCA) was also used to identify outlier samples that
would potentially introduce latent variation into the analysis of differential expression
across sample groups.
Multivariate Principal Component Analysis was performed on the normalized
data set using the covariance matrix. Univariate linear modeling of sample groups was
performed by ANOVA. The magnitude of the response (fold-change calculated using the
least square mean) and the p-value associated with each probe set and binary comparison
were calculated, as well as a “step-up” adjusted p-value for the purpose of controlling
false discovery rate (Benjamini, Y, and Y Hochberg, 1995)
Data were analyzed by Gene Set Enrichment (Partek), which uses a right-tailed
Fisher’s Exact test with a null hypothesis that data are changing together strictly by
chance. The alternative is that the data change in concert because they are part of a
biological gene set of pathway. Functional clusters and pathways were identified using
the DAVID bioinformatics resource (Huang et al. 2009).
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Chapter 3: RESULTS

3.1 A combination of protease digestion (collagenase/dispase) and gentle agitation
effectively removes epicardial cells from the surface of the adult mouse heart

To obtain primary epicardial cells for gene expression assays, we sought to
prospectively isolate cells from the surfaces of adult mouse hearts (C57BL/6J males, 10
weeks old). In preliminary experiments, we attempted a fast (15 minute) digestion
approach by incubating hearts in 0.025% trypsin. Isolated primary mouse cells were kept
for 24 hours in a minimal medium (α –MEM supplemented with 1% FBS and 10 μM
cyclosporine A). Problematically, however, this approach yielded a cell population
abundant with spindle-shaped fibroblasts, but that contained few epicardial cells
(rounded, epithelial-like morphology) (Fig. 3A).
Instead of using trypsin, we next attempted to incubate whole mouse hearts for 2
hours in a modified saline solution (HBSS) containing collagenase/dispase (5 mg/mL)
and 10 μM cyclosporine A. Using this digestion solution, we obtained an average of
15,000 ± 3,100 cells/heart. In contrast to trypsinization, we found that the
collagenase/dispase-based digestion method enriched for epithelial-like cells. Some cells
adhered in groups (clusters), while others adhered as individual cells. Cells obtained by
collagenase/dispase digestion could be maintained in culture for over 1 week (Figs. 3BD). Notably, in contrast to epicardial explant culture, this method removed epicardial
cells directly from the cover of the heart that could be immediately used for isolation of
total RNA or protein, or, further enriched by MACS or FACS (see below).
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Figure 3. Optimization of heart digest conditions for mouse epicardial cells. (A) Cells cultured for 24hours after heart digest in 0.025% trypsin at 37°C for 15 minutes. (B) Digest in 50 μg/mL
collagenase/dispase yields very few cells. (C) After 2 hour digest with gentle agitation with 5 mg/mL
collagenase/dispase, we prospectively isolated primary epicardial cells. (D) One week after digest,
epicardial cells with a characteristic cobblestone-like morphology expanded in culture as a single layer and
as clusters of cells.
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3.2 Isolation of primary adult Keratin-18+ epicardial cells.
After collagenase/dispase digestion, to further enrich for epicardial cells, we
immediately sorted cells by MACS. For MACS we used a primary antibody (Rat antiMouse CD104) followed by a secondary antibody (Goat-anti Rat IgG) that was
conjugated to paramagnetic microbeads. After elution from the MACS column, the
resulting cells were cultured for 24 hours, fixed, and permeabilized. We then performed
immunofluorescence staining to detect Keratin 18, an epicardial-specific intermediate
filament protein in the heart, with an anti-Keratin-18 antibody. Lastly, cells were
counterstained with 4',6-diamidino-2-phenylindole (DAPI) to identify cell nuclei. After
24 hours in culture, the number of Keratin+/DAPI+ cells differed significantly between
wells containing pre-MACS cells (Fig. 4A), cells from the negative MACS fraction
(CD104-negative) (Fig. 4B), and cells from the positive MACS fraction (CD104positive) (Fig. 4C) (ANOVA, p < 0.001, F = 13.5).
Surprisingly, even prior to CD104 MACS, most of cell population isolated by
collagenase/dispase digestion was Keratin-18+ (82 ± 9 % of total DAPI+ cells). After
CD104 MACS, there were additional Keratin-18+ cells (88 ± 10% of total DAPI+ cells)
(Table 1), however, CD104 MACS did not significantly increase the number of Keratin18+ cells (2-tailed t-test, p = 0.055). Notably, after 1 week of culture, we did not observe
mesenchymal cells, suggesting that the CD104-isolated cells had not undergone EMT
(Fig. 4D).
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Table 1. Heart digest method selects for epicardial cells and is used to demonstrate gross
differences in epicardial cells after running-exercise. An average total cell count (N = 3 experiments, 5
hearts/experiment) is reported for running-conditioned and littermate control mice.

Cell Population

+

Keratin-18 : DAPI

+

Running Exercise

Control

Pre-sort

82 ± 9.9%

57,433 ± 10,500 cells

38,296 ± 7150 cells

Post-sort (CD104+)

88 ± 10.2%

39,533 ± 1750 cells

21,778 ± 6500 cells
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Figure 4. CD104 MACS enriches for Keratin-18+ cells. Cells were allowed to adhere for 24 hours before
fixation. Immunofluorescent detection of Keratin-18 (300 ms exposure) and DAPI (20 ms exposure),
Images captured at 40x. (A) Before sort, the heart digest technique provides a population abundant in
Keratin-18+ cells. (B) Fewer Keratin-18+ cells exist in culture in the post-sort negative fraction fixed 24
hours after enzymatic digest. (C) Culture is abundant in Keratin-18+ cells after CD104 MACS. (D) One
week after digest, cells from the CD104+ MACS population expand in culture and maintain a cobblestonelike morphology. Keratin-18+ intermediate filaments are still expressed.
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3.3 Greater overall number of epicardial cells isolated from hearts of running
mice
Mice were allowed to run ad libitum for 1 week prior to epicardial cell isolation.
We measured the distance run each day by odometer and observed that mice primarily
ran at night, with an average distance of 7.32 ± 2.90 km/day (4.55 ± 1.80 miles/day, n =
4). Of interest, we performed cell counts after CD104 MACS and observed a significant
increase in total number of cells per heart for isolates from running mice (Control mice:
15,000 ± 3,100 cells/heart; Running mice: 38,300 ± 7,100 cells/heart; n=5 mice per
group; 2-tailed t-test, p < 0.01). Spectrophotometer measurements after total RNA
isolation showed that we obtained 27.4 ± 6.5 ng/µL of RNA from control mice (n = 10
total) and 74.0 ± 2.7 ng/µl of RNA from running-exercised mice (n = 10 total).

3.4 Microarray assays and bioinformatic analysis to determine epicardial cell gene
expression in runners and non-runners
To examine epicardial gene expression for runners and non-runners, we pooled
epicardial cells isolated by CD104 MACS from the hearts of healthy control mice and
those that ran ad libitum for 1 week (n =5/group). Based on our unpublished observations
from epicardial cell lineage-tracing studies in transgenic mice at 2 weeks after runningexercise (Rao et al., under review), we hypothesized that we could capture an active
transcriptional response in running mice after 1 week of running that would differ from
that of non-runners. Samples were pooled to help normalize: 1) Variation in the number
of epicardial cells isolated from individual mice (e.g., low relative cell number isolated
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from controls), and 2) Variation in the distance run among runners. For runners and nonrunners, global gene transcription profiles were generated from fresh isolates of
epicardial cells that were immediately lysed for total RNA isolation; this RNA was used
to produce biotinylated cDNA probes. The cDNA probes were then hybridized to
Affymetrix cDNA microarrays (GeneChip Mouse Gene 2.0 ST Array).
For bioinformatic analysis, gene expression data were averaged for 2 samples (n =
5 mice /sample), statistically-filtered (Cut-off of 2.0 for relative log expression [RLE]),
and analyzed for quality control, based on the variation of the median and quartiles probe
set intensities (See Appendix, Figure 6). To perform functional clustering, the filtered
gene expression data were entered into the Database for Annotation, Visualization, and
Integrated Discovery (DAVID) (Huang et al., 2009) and also grouped according to Gene
Onology (GO) terms. This analysis identified genes with significant changes in
expression and grouped them into 3 major GO domains: Biological process, Cellular
process, and Molecular function. At a higher level of resolution, we examined the top GO
terms identified from each of the 3 categories. These genes belonged to: “extracellular
matrix” (ECM), GO:0031012; “nucleic acid binding transcription factor activity”,
GO:0001071; and “reproductive”, GO:0022414 (Fig. 5). Based on our interests in
angiogenesis, vascular rescue/repair, and perfusion, in addition to the 3 major GO termassociated gene sets, we also focused our attention on vascular-related gene expression.

24

Figure 5. Functional clustering from DAVID analysis using GO domain filters. Top results from each
category shown.
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3.4.1 Changes in “Reproductive Process” of the GO biological process domain
Within the GO domain for biological processes, the GO term (GO:0022414),
“reproductive,” filtered 1250 transcripts, of which 110 significantly differed between
samples (p < 0.05) (Table 2). Our results demonstrated a significant decrease (p < 0.01)
in gene expression for the mitochondrial proteins Bcl2 (fold-change = -1.27) and Immpl1
(fold-change = - 1.41), as well as Prdx4, a member of the peroxiredoxin family (foldchange = -1.61). We also observed a significant increase (p < 0.01) in gene expression for
Lrp6, a Wnt-signaling receptor (fold-change = 1.13).

Table 2. Reproductive Genes and Fold-Change in Response to Running Exercise.
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3.4.2 Changes in the “Extracellular Matrix” of the cellular process GO domain
We found that 386 gene transcripts clustered with the GO term for ECM
(GO:0031012). Running induced a significant change for 36 ECM-associated genes in
isolated CD104+ epicardial cells (p < 0.05) (Table 3); these included genes with
upregulated expression: glypican 5 (Gpc5), ladinin (Lad1), collagen, type VII, alpha 1
(Col7a1); and those that were down-regulated: vitrin (Vit), collagen, type VI, alpha 1
(Col6a1). We selected these transcripts based on our interest in extracellular matrix
remodeling and/or involvement in cell migration.

Table 3. ECM-related Genes and Fold-Change in Response to Running Exercise.
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3.4.3 Changes in vascular-related genes and in “Nucleic Acid Transcription Factor
Binding” genes from the Molecular Function GO domain
We found that 1088 genes clustered with the GO term “nucleic acid transcription
factor binding” (GO:0001071). Eighty-two of these differed significantly between the
samples from runners and non-runners (p < 0.05). Within the Forkhead box (FOX) family
of transcription factors, mRNAs for FoxA3, FoxG1, and FoxS1 were significantly
upregulated (p < 0.05) (Table 4). Of note, gene expression for TCF21, an important
transcription factor for fibroblast specification, was down-regulated in isolated epicardial
cells of runners compared with non-runners (Table 4).
Regarding the ability of epicardial cells to contribute to neovascularization, our
microarray analysis indicated a significant (p < 0.05) increase in gene transcription for
vascular endothelial growth factor B (Vegfb; fold change = 1.36), endothelin-3 (Edn3;
fold change = 1.23), and angiogenin-6 (Ang6; fold change = 1.35) (Table 5).
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Table 4. Transcription factor-related Genes and Fold-Change in Response to Running Exercise.

Table 5. Vasculature-related Genes and Fold-Change in Response to Running Exercise.
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3.4.4 Running-exercise significantly changes transcript expression compared with
control mice.
Of the 41,345 transcripts identified by microarray, expression of Snord116
increased the most in running-exercised mice (fold-change = 7.08, p-value = 0.044) and
Igk-V28 decreased the most in running-exercised mice (fold-change = -3.84, p = 0.037).
We list the transcripts with the largest fold-change that were significantly different
between running-exercised and control mice in Table 6.

Table 6. Gene expression data for the most prominent fold-changes from running-exercised (“Running”)
mice. Left, increases in transcript fold-change and Right, decrease in transcript fold change, relative to
the running-exercised sample.
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Chapter 4: DISCUSSION

4.1 Advantages and limitations of our method for isolation of primary murine
epicardial cells

To isolate primary epicardial cells directly from the adult mouse heart, we
developed a protocol that minimized exposure to cell culture plastic and medium. We
used collagenase/dispase to digest ECM components (Gibson et al. 1989; Hu et al. 2006;
Oseni et al. 2013), since trypsin can potentially destroy cell surface epitopes (such as
CD104) and other proteins (Shoelson et al. 1988; Nakayama et al. 2004; Huang et al.
2010). Although some commercially available products require less than 1 hour for cell
isolation, they yield a highly heterogeneous cell population because they completely
dissociate cardiac tissue (e.g. MACS Tissue Dissociation Kits, Miltenyi Biotech). Our
method required 2 hours, but primarily isolated epicardial cells directly from the heart
cover. Furthermore, to increase cell survival, we used the mitochondrial transition pore
inhibitor cyclosporine A (CsA, 10 μM) (Zamzami et al. 1996; Jung et al. 2008;
Sachewsky et al. 2014). Although this concentration of CsA increased cell viability, in
the future we will generate survival curves to identify an optimal CsA concentration.
Differing from currently published isolation methods for adult epicardial cells and
EPDC, our protocol employed CD104 MACS. In the future, further enrichment by FACS
may be possible with a second primary antibody specific to a different cell surface
protein on epicardial cells. To further purify native epicardial cells, we could also try to
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remove contaminating blood cells with antibodies to CD45 (CD45 MACS). In this case,
the CD45-negative fraction would then be used for CD104 MACS.

4.2 Transcriptional profiling of undifferentiated CD104+epicardial cells isolated
from the hearts of running-exercised and non-running mice

Based on the role(s) that epicardial cells play in blood vessel formation during
cardiac development and vascular repair after injury (Smart et al. 2007; Smart et al.
2010), we hypothesized that undifferentiated (CD104+/K18+) epicardial cells contribute
to angiogenesis and/or vascular remodeling during cardiac hypertrophy due to running
exercise. In order to address this experimentally, we developed a protocol for primary
epicardial cell isolation directly from the cover of the adult murine heart and used it to
compare global gene expression profiles of epicardial cells isolated from the hearts of
mice that engaged in running-exercise for 1 week to those of healthy, non-running mice
that served as controls. Because epicardial cells may undergo EMT during running
exercise to directly form microvascular endothelial cells, or engage in paracrine activity
that supports angiogenesis, understanding changes in gene transcription that occur in
native epicardial cells from the heart surface may provide insight into key molecules or
signaling pathways that can be targeted to provide benefit to patients with cardiac injury.
For our running-exercise paradigm, mice were housed either with or without a
running wheel for 1 week before heart digest and epicardial cell isolation. We chose the
1-week time point in order to capture early transcriptional changes of the epicardium in
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running-exercised mice. To address potential variability between mice in the same group
(running or non-running), we pooled samples from each condition (n =5 mice per group).
Notably, while this approach provides a reasonable overall picture of gene activity within
a group (i.e., runners or non-runners), it does not allow us to correlate actual running
distance for mouse “A” with specific transcript changes in mouse “A”. For future studies,
attaining this level of resolution may be possible with further improvements in cell
isolation to obtain greater amounts of material, RNA isolation efficiency, and gene
profiling technology.
To identify primary epicardial cells, we performed immunocytochemistry for
Keratin 18, an epithelial intermediate filament protein expressed by epicardial cells on
the cover of the heart, but not by other cardiac cell-types. After cell isolation, we
consistently obtained a greater number of epicardial cells (K18 +) from heart digests of
running-exercised mice compared with non-runners. Importantly, we found this to be the
case both before and after CD104 MACS, indicating that the difference may relate to the
condition of the heart prior to tissue digestion/cell isolation. For example, the
composition of ECM components could be altered during remodeling in response to
running. Of interest, our microarray analysis supports this hypothesis as demonstrated by:
1) Functional clusters from DAVID analysis, 2) GO term enrichment scores for ECM,
and 3) Expression data for particular ECM-related genes. Altogether, our data for ECMrelated gene expression in epicardial cells from runners and non-runners suggest a pattern
of ECM degradation and remodeling in runners; this may explain the observed increase
in overall number of epicardial cells obtained after heart digestion with
33

collagenase/dispase. Accordingly, the overall amount of collagen or compliment of
collagen species present in the epicardial basement membrane may differ between
runners and non-runners. To address this question, we have repeated our running study
and isolated CD104+ epicardial cells from the hearts of individual mice (Non-runners,
21,778 ± 6,500 cells per heart; Runners, 39,533 ± 1,750 cells per heart; N=5 hearts per
condition). Using these cells, further studies may examine candidate ECM proteins or
ECM-related proteins by Western blot or ELISA to verify the preliminary microarray
screen (some candidates are listed below in 4.2).

4.3 Running-exercise modifies the expression of gene transcripts listed under the
“Reproductive” GO term

Running exercise may affect mitochondrial function in epicardial cells (or, a
subpopulation thereof) to promote an “activated state” before subsequent migration
through the subepicardial extracellular matrix (Kocabas et al. 2012). In our analysis, we
identified a significant decrease (p < 0.01) in the inner mitochondria membrane peptidase
Immp2l (fold change = -1.41) and the outer mitochondrial membrane protein Bcl2 (fold
change = -1.27). Lu et al. (2008) show an increase in ATP production in isolated
mitochondria from Immp2l deficient mice, which might be advantageous for activated
epicardial cells (Lu et al. 2008). The role of the pro-survival protein, Bcl2, is tissuespecific and context dependent (Reviewed in Sochalska et al. 2015). In future
experiments, it would be interesting to measure metabolic changes such as oxygen
consumption, ATP production, and/or glycolytic flux to determine whether there are
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differences in bioenergetics between running-exercised epicardial cells and those of nonrunners.
We observed a subtle, yet significant increase in expression in epicardial cells
from exercised mice of low-density lipoprotein receptor-related protein 6 (Lrp6; fold
change = 1.13, p < 0.05). In our lab, we identified Lrp6 as an epicardial cell surface
receptor for CTGF-D4 that mediates EPDC graft success by increasing Sox9 levels,
which regulates Endothelin Receptor B expression; this receptor is required for EPDC
proliferation and migration after MI (Rao et al., PhD dissertation; University of
Vermont).

4.4 Epicardial gene expression suggests extracellular matrix remodeling in the
running heart
Many genes that grouped with the GO term ECM such as MMP10 and ADAM
family members indicate that running may induce ECM degradation or modification
(Appendix 1). Running-induced cardiac hypertrophy may require remodeling of
extracellular matrix proteins that form the epicardial basement membrane. For example,
strain on the heart or increase in heart size may elicit changes in relative concentration or
composition of different collagen isoforms. Col7a1 contributes to matrix adhesion by
anchoring collagen fibrils to adhesion molecules; its expression significantly decreases in
epicardial cells lacking PDGFR, which contributes to epicardial EMT failure (Sakai et al.
1986; Chung & Uitto 2010; Smith et al. 2011). In our data set, gene expression for other
collagen isoforms, such as Col6a1, was significantly down-regulated (fold change = -
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1.30, p < 0.05). In 2012, Luther et al. (2012) demonstrated that after permanent occlusion
of the left anterior descending artery, mice deficient in Col6a1 (Col6a1-/-) had decreased
collagen deposition after surgery and an unexpected improvement in cardiac function as
assessed by echocardiography (Luther et al. 2012). These results suggest that the absence
of Col6a may benefit cardiac function and remodeling after infarction.
We observed significant increases (p < 0.05) in gene expression for both
structural and signaling ECM components including the anchoring protein Lad1 (a.k.a.
Col17A1 ectodomain, fold change = 1.35) and GPI-anchored glypican, GPC5 (foldchange = 1.49), which is likely involved in growth factor signal transduction (Moll &
Moll 1998; Franzke et al. 2002; Walko et al. 2015; Ibrahimi et al. 2004; Williamson et al.
2007; Li et al. 2011; Filmus & Capurro 2014). In cancer, Lad1 down-regulation during
metastatic EMT contributes to overall ECM re-arrangement (Thomson et al. 2011;
Gröger et al. 2012). Based on this observation, we predict that Lad1 upregulation
supports the increase in epicardial cell density in running-exercised mice. To better
understand the role of GPC5, we could use immunocytochemistry to determine its
cellular localization/distribution.
Of interest, running may also require various components of the subepicardial
extracellular matrix to be degraded to allow for EPDC migration after epicardial EMT
(Combs et al. 2011; Tao et al. 2013). We observed a decrease (fold change = -1.73) in the
matrix-assembly protein Vitrin (Whittaker & Hynes 2002).

4.5 Running induces vasculature-related signaling in epicardial cells

36

Cardiomyocytes require neovascularization to support exercised-induced
ventricular hypertrophy and we expected running-exercise to induce cardiac
angiogenesis. By microarray assays, although the transcript for VEGF-A did not change,
the transcript for VEGFB increased by 1.36-fold (p = 0.07) in runners compared with
non-runners. VEGFB is a selective ligand for Flt-1 (VEGFR-1) and VEGFB signaling
that supports vascular development in the heart and angiogenesis (Olofsson et al. 1996;
Cross et al. 2003; Lähteenvuo et al. 2009; Jensen et al. 2015). After ischemic injury,
VEGFB is reported to act as a blood vessel survival factor, rather than a proliferation or
growth factor (Bellomo et al. 2000; Wright 2002; Zhang et al. 2009)
Avian EPDC were shown to contribute endothelial cells during development and
the authors suggested that VEGF or PDGF signaling may be involved (Pérez-Pomares et
al. 2002; Guadix et al. 2006). At present, it is controversial whether adult EPDC in
mammals are shifted toward an endothelial cell fate after MI. In mice, Zamora et al.
(2007) found that an epicardial β-catenin was required for coronary artery formation.
Although their data did not demonstrate direct differentiation from epicardial cells to
endothelial cells per se, their results do suggest a requirement for EPDC signaling in
vascular development (Zamora et al. 2007). Overexpression of prokineticin receptor-1 in
cardiomyocytes promotes EPDC differentiation to endothelial cells in explant culture;
this suggests that EPDC-derived endothelial cells may participate in neovascularization
(Urayama et al. 2008).
We observed an increase in Edn3 transcript expression (fold-change = 1.23, p <
0.01) in response to running exercise. Both hypoxic conditions and the vasoactive
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protein endothelin-3 (EDN3) can stimulate VEGF production, as detected by both
luciferase/VEGF promoter reporter activity and anti-VEGF antibody (Rao et al. 1991;
Levy et al. 1995; Pedram et al. 1997). EDN3 was shown to stimulate endothelial cell
migration in culture (Morbidelli et al. 1995).
In running-exercised mice, the gene transcript for Ang6 significantly increased
(fold change = 1.35, p < 0.05). A known angiogenic ribonuclease, soluble angiogenin
binds endothelial cell surface receptors, is endocytosed, and then is trafficked to the
nucleus where it participates in ribosomal RNA transcription (Moroianu & Riordan 1994;
Adams & Subramanian 1999; Xu et al. 2002). Endocytosis and nuclear trafficking of
angiogenin is critical to [calf pulmonary artery] endothelial cell proliferation (Moroianu
& Riordan 1994). Kishimoto et al. (2005) demonstrated that the nuclear translocation of
angiogenin is required for VEGF-stimulated angiogenesis (Kishimoto et al. 2005).

4.6 FOX and ETS transcription factors expression increases in epicardial cells
after running exercise

In our microarray analysis, we identified the upregulation of members of the FOX
family of transcription factors that are involved in cellular differentiation and vascular
development. For example, FoxG1 is critical for differentiation of thymic epithelial cells,
neural cells, and embryonic stem cells (Wei & Condie 2011; Yamamizu et al. 2013;
Pancrazi et al. 2015). FoxA3 regulates hematopoetic stem and progenitor cell survival
and, in combination with tumor necrosis factor receptor 1, promotes liver regeneration
(Holmfeldt et al. 2016; Wangensteen et al. 2015). Using a FoxS1 knock-in reporter
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mouse, Heglind et al. (2005) demonstrated FoxS1 expression in vascular smooth muscle
cells and pericytes on the brain surface (Heglind et al. 2005). FoxS1 is also expressed in
pericytes and Sertoli cells of fetal testis and is required for the development of testicular
vasculature, as shown in FoxS1 deficient mice (Sato et al. 2008). FoxS1 is part of a major
regulatory network that promotes fibroblast to myofibroblast differentiation (Noizet et al.
2015). In epicardial cells, it is likely that a combination of FOX and ETS transcription
factors regulate both cell differentiation and endothelial gene expression via the FOX:
ETS motif (Dejana et al. 2007; De Val et al. 2008).

4.7 Changes in epicardial gene expression: implications for human health and
disease

Our microarray data have potential to impact human health and disease treatment.
Among all transcripts, Snord116 (HBII-85) was upregulated the most in epicardial cells
from running mice (~7-fold, p> 0.05). The Snord116 locus contains multiple snoRNAs
and is best known for its role in alternative splicing of the serotonin receptor gene in
mammals (Schüle et al. 2005; Skryabin et al. 2007). Among non-coding RNAs, C/D box
small nucleolar RNAs (snoRNA) help direct rRNA modifications (2’-O-ribose
methylation) and facilitate pre-mRNA splicing (Kiss 2002; Yin et al. 2012). Importantly,
the Snord116 locus controls the expression of approximately 200 genes (coding regions).
As such, snoRNAs from the Snord116 locus may regulate some of the metabolic changes
that occur in response to running exercise.
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Translocation or deletion of the Snord116 locus was shown to contribute to a rare
neurodevelopmental disorder called Prader-Willis Syndrome (PWS) (Bieth et al. 2015;
Zieba et al. 2015). Mouse models of PWS have been developed that share several
phenotypic characteristics with patients (Ding et al. 2008). Snord116-deficient mice
(Snord116-/-) were shown to both eat more and expend more energy than did control mice
(Snord116+/+) (Qi et al. 2016). For our work, it is clearly of interest to determine whether
changes in epicardial cells contribute to the altered metabolism of Snord116 -/- mice. Also,
compared with wildtype mice, would Snord116-/- mice be physically capable of running
for similar distance and duration? Does exercise promote ventricular hypertrophy in
Snord116-deficient mice? If so, will the observed changes in gene expression for
extracellular matrix proteins, vascular signaling proteins, and transcription factors that
occur in the epicardial cells of wildtype running mice be maintained in running Snord116
deficient mice? Such investigations could provide interesting insights into PWS
manifestation as well as rationale for drug development.
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This analysis was originally designed to screen for epicardial-specific factors that
promote cardiovascular perfusion by either direct differentiation (endothelial lineage
specification) or through indirect paracrine signaling mechanisms (angiogenesis). For
direct differentiation, it may be possible to prime epicardial cells ex vivo for endothelial
specification prior to delivery by tangential injection into the subepicardium after MI.
Our research group has shown that subepicardial injection can markedly improve graft
success after MI (Iso, et al. 2014). In terms of paracrine activity, specific factors
identified in running-exercised mice may either protect existing blood vessels or
stimulate new vessel growth. To this end, our microarray analysis could serve as a
valuable screen for epicardial-derived factors with potential to act as powerful angiogenic
therapeutics either alone or in combination.
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Appendix 1. Extracellular-matrix related GO term changes (p < 0.05)
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Appendix 2. Nucleic Acid Transcription Factor Binding GO term changes (p < 0.05)
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Appendix 3. Reproductive GO term changes (p < 0.05)
55

Gene Symbol
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Prdx4
Ddx4
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Lrp6
Atp8b3
Syce1
Cul7
Nr2f2
Meig1
Jag2
Th
Map2k1
Birc6
Plekha1
Corin
Ift81
Angpt1
Dicer1
Cdh1
Exo1
Atm
Zfp37
Rad23b
Fancl
Smc3
Rps6
Rad21l
Kitl
Tle3
Tiparp
Stk3
Dld
Golga3
Bptf
Lgr5
Src
Aurka
Rnase9
Mir34b
Chd7
Magoh
Ttc26
Ift88
Stag3
Foxa3
Plk1

RefSeq
p-value Fold-changeDescription
NM_009741
0.000337
-1.26863 R down vs C
NM_178753
0.00045
-1.35393 R down vs C
NM_016764
0.000473
-1.61472 R down vs C
NM_001145885 0.000878
1.23375 R up vs C
ENSMUST00000134965
0.001299
-1.40526 R down vs C
NM_008514
0.001843
1.12648 R up vs C
NM_026094
0.00206
1.20365 R up vs C
NM_001143765 0.002348
1.1989 R up vs C
NM_025611
0.002531
1.19327 R up vs C
NM_183261
0.004946
1.1682 R up vs C
ENSMUST00000115083
0.005948
-1.6268 R down vs C
NM_010588
0.006431
1.11351 R up vs C
ENSMUST00000000219
0.007041
1.21415 R up vs C
NM_008927
0.007998
-1.16327 R down vs C
NM_007566
0.00851
-1.11453 R down vs C
NM_133942
0.009155
-1.24818 R down vs C
NM_016869
0.010197
1.20051 R up vs C
NM_009879
0.010946
-1.61298 R down vs C
ENSMUST00000022921
0.0113
-1.84062 R down vs C
NM_148948
0.011597
-1.20149 R down vs C
NM_009864
0.011853
-1.22617 R down vs C
NM_012012
0.011946
1.54586 R up vs C
NM_007499
0.01197
-1.41555 R down vs C
NM_009554
0.013281
1.09552 R up vs C
NM_009011
0.013461
-1.13956 R down vs C
ENSMUST00000004120
0.01347
-1.47642 R down vs C
NM_007790
0.013632
-1.17291 R down vs C
NM_009096
0.014052
-1.03026 R down vs C
NM_001114677 0.014082
1.21252 R up vs C
ENSMUST00000105283
0.014372
-1.24251 R down vs C
NM_001083927 0.014802
1.12531 R up vs C
NM_178892
0.015107
-1.56611 R down vs C
NM_019635
0.015633
-1.42692 R down vs C
NM_007861
0.015677
-1.351 R down vs C
ENSMUST00000112512
0.015776
-1.28204 R down vs C
NM_176850
0.016261
-1.09183 R down vs C
NM_010195
0.016527
-1.2999 R down vs C
ENSMUST00000109533
0.017835
-1.18975 R down vs C
NM_011497
0.017905
1.48953 R up vs C
NM_183032
0.018282
1.29313 R up vs C
NR_029655
0.018371
1.76618 R up vs C
ENSMUST00000051558
0.018425
-1.13204 R down vs C
ENSMUST00000030348
0.018967
-1.38423 R down vs C
ENSMUST00000162554
0.019519
-1.24241 R down vs C
NM_009376
0.019866
-1.21459 R down vs C
NM_016964
0.020232
1.59994 R up vs C
NM_008260
0.021477
1.37347 R up vs C
NM_011121
0.021584
1.34933 R up vs C
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Gene Symbol RefSeq
p-value Fold-changeDescription
Tubd1
NM_001199045 0.022088
-1.47585 R down vs C
Gm16405
NM_001166646 0.022274
1.62965 R up vs C
Sos1
NM_009231
0.023653
-1.15704 R down vs C
Gm16405
NM_001166646 0.024036
1.63986 R up vs C
Tial1
ENSMUST00000106226
0.024081
-1.2188 R down vs C
Spata18
ENSMUST00000071077
0.024163
1.29712 R up vs C
Mlh3
NM_175337
0.024182
-1.52851 R down vs C
Mnd1
NM_029797
0.02553
-1.71702 R down vs C
Larp7
NM_138593
0.025623
-1.24027 R down vs C
Top2a
NM_011623
0.025679
1.26988 R up vs C
Dnajb6
ENSMUST00000008733
0.026432
-1.1576 R down vs C
Ggn
NM_182694
0.0273
1.19814 R up vs C
Mir449c
NR_030452
0.028143
1.38545 R up vs C
Mlh1
NM_026810
0.02847
-1.22918 R down vs C
Strbp
NM_009261
0.028915
-1.20595 R down vs C
Fzd5
NM_022721
0.028933
1.04561 R up vs C
Spaca3
ENSMUST00000103223
0.029877
1.24536 R up vs C
Edn2
ENSMUST00000030384
0.030225
1.12367 R up vs C
Tdrd7
ENSMUST00000102929
0.030642
-1.21717 R down vs C
Adam26a
NM_010085
0.030944
1.14646 R up vs C
Ror2
NM_013846
0.031222
1.29694 R up vs C
Racgap1
NM_012025
0.031762
1.349 R up vs C
Tbata
NM_001017433 0.032369
1.31109 R up vs C
Spin1
NM_011462
0.033071
-1.27487 R down vs C
Trp63
NM_001127259 0.033143
1.21736 R up vs C
Gm16405
NM_001166646 0.034552
1.56139 R up vs C
Klf17
NM_029416
0.034598
1.17917 R up vs C
Rbm7
NR_037589
0.034704
-1.355 R down vs C
Arid4a
NM_001081195 0.034786
-1.25435 R down vs C
Prss29
NM_053260
0.035283
1.32047 R up vs C
Bmpr1b
NM_007560
0.035595
-1.41594 R down vs C
Senp2
NR_027488
0.035667
-1.36295 R down vs C
Tcp1
ENSMUST00000129632
0.036353
-1.36122 R down vs C
Xlr5b
ENSMUST00000114518
0.036592
1.25332 R up vs C
Ccdc155
ENSMUST00000121017
0.036816
1.2357 R up vs C
Xlr5a
NM_001045539 0.038287
1.34647 R up vs C
Insl6
NM_013754
0.038308
-1.36024 R down vs C
Mastl
ENSMUST00000028119
0.038891
-1.24928 R down vs C
Zpbp
ENSMUST00000020413
0.039527
-1.22044 R down vs C
Nme5
NM_080637
0.039912
-1.98329 R down vs C
Nrip1
ENSMUST00000121927
0.040525
-1.14789 R down vs C
3830403N18Rik NM_027510
0.041356
-1.5917 R down vs C
Ggt1
ENSMUST00000006508
0.041362
1.24216 R up vs C
Ube2a
NM_019668
0.042862
-1.43152 R down vs C
Zfx
NM_001044386 0.043985
-1.29493 R down vs C
Xlr3b
NM_001081643 0.044181
-3.1188 R down vs C
Dmrtc2
NM_027732
0.044312
1.3555 R up vs C
Gm16405
NM_001166646 0.046434
1.52703 R up vs C
Myocd
NM_145136
0.046473
1.24754 R up vs C
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Gene Symbol
Klhdc3
Sly
Sly
Plcb1
Syna
Ubr2
Tmf1
Pank2
Gm16405
Gm16405
Ada
Rpa1
Cr1l

RefSeq
p-value Fold-changeDescription
NM_027910
0.046614
-1.22938 R down vs C
NM_201530
0.047469
3.1055 R up vs C
NM_201530
0.047469
3.1055 R up vs C
NM_001145830 0.047543
-1.22738 R down vs C
NM_001013751 0.047634
1.21241 R up vs C
NM_146078
0.048423
-1.1173 R down vs C
NM_001081111 0.048762
-1.29388 R down vs C
NM_153501
0.048945
-1.32359 R down vs C
NM_001166646 0.049326
1.56571 R up vs C
NM_001166646 0.049326
1.56571 R up vs C
ENSMUST00000017841
0.049698
-1.10595 R down vs C
NM_001164223 0.049822
-1.18088 R down vs C
NM_013499
0.049854
-1.21465 R down vs C
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